CITADEL ADVISORS LLC

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Back to TRVI Full portfolio

Position in TRVI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,333,763

+$12,420,019 QoQ

Shares Held

1,201,489

+686.0% QoQ

Ownership

0.846%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

16 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Derivatives in TRVI

reported options exposure · as of Mar 31, 2026

CallValue

$1,253,843

CallShares

105,100

PutValue

$558,324

PutShares

46,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,537,601 across 374 Biotechnology names. TRVI ranks #76 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	2,182,571	$356,894,009
2	ONC	BeOne Medicines Ltd.	1,032,298	$306,561,536
3	BMRN	Biomarin Pharmaceutical Inc	4,512,634	$254,918,694
4	JAZZ	Jazz Pharmaceuticals plc	1,259,444	$238,097,887
5	MDGL	Madrigal Pharmaceuticals, Inc.	453,843	$237,573,195
6	BBIO	BridgeBio Pharma, Inc.	3,173,940	$235,696,783
7	TERN	Terns Pharmaceuticals, Inc.	3,218,810	$169,695,662
8	PTGX	Protagonist Therapeutics, Inc	1,551,900	$163,570,260

All Filings in TRVI

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$558,324	46,800	-55.5%	Put	Defined	2026-05-15
2026-03-31	$1,253,843	105,100	-91.3%	Call	Defined	2026-05-15
2026-03-31	$14,333,763	1,201,489	+686.0%	Shares	Defined	2026-05-15
2025-12-31	$1,913,744	152,855	+69.8%	Shares	Defined	2026-02-17
2025-12-31	$1,126,800	90,000	+70.1%	Put	Defined	2026-02-17
2025-12-31	$662,308	52,900	-48.4%	Call	Defined	2026-02-17
2025-09-30	$938,185	102,534	-55.8%	Shares	Defined	2025-11-14
2025-09-30	$2,122,800	232,000	+417.9%	Put	Defined	2025-11-14
2025-09-30	$409,920	44,800	-47.5%	Call	Defined	2025-11-14
2025-06-30	$467,138	85,400	-93.5%	Put	Defined	2025-08-14
2025-06-30	$7,216,385	1,319,266	+564.3%	Shares	Defined	2025-08-14
2025-06-30	$1,086,342	198,600	+609.3%	Call	Defined	2025-08-14
2025-03-31	$176,120	28,000	-74.1%	Put	Defined	2025-05-15
2025-03-31	$680,578	108,200	+529.1%	Call	Defined	2025-05-15
2024-12-31	$70,864	17,200	-65.3%	Call	Defined	2025-02-14
2024-12-31	$203,940	49,500	-96.0%	Put	Defined	2025-02-14
2024-12-31	$5,080,684	1,233,176	+205429.3%	Shares	Defined	2025-02-14
2024-09-30	$2,004	600	-98.8%	Call	Defined	2024-11-14
2024-09-30	$166,602	49,881	+1008.5%	Shares	Defined	2024-11-14
2024-09-30	$15,030	4,500	-84.3%	Put	Defined	2024-11-14
2024-03-31	$98,946	28,680	+4680.0%	Shares	Defined	2024-05-15
2024-03-31	$2,070	600	-72.7%	Put	Defined	2024-05-15
2024-03-31	$7,590	2,200	+22.2%	Call	Defined	2024-05-15
2023-12-31	$2,412	1,800	-40.0%	Call	Defined	2024-02-14
2023-12-31	$4,020	3,000	-98.4%	Put	Defined	2024-02-14
2023-12-31	$247,977	185,058	+583.3%	Shares	Defined	2024-02-14
2023-09-30	$59,035	27,081	-55.2%	Shares	Defined	2023-11-14
2023-06-30	$144,482	60,453	+5945.3%	Shares	Defined	2023-08-14
2023-06-30	$2,390	1,000	-97.9%	Call	Defined	2023-08-14
2023-03-31	$87,690	47,400	-33.8%	Put	Defined	2023-05-15
2023-03-31	$132,561	71,655	+6414.1%	Shares	Defined	2023-05-15
2023-03-31	$2,035	1,100	-97.5%	Call	Defined	2023-05-15
2022-12-31	$85,336	44,216	+3584.7%	Shares	Defined	2023-02-14
2022-12-31	$2,316	1,200	-89.5%	Call	Defined	2023-02-14
2022-12-31	$22,002	11,400	-77.1%	Put	Defined	2023-02-14
2021-12-31	$38,981	49,849	+174.7%	Shares	Defined	2022-02-14
2021-09-30	$25,405	18,147	+70.9%	Shares	Defined	2021-11-15
2021-03-31	$28,772	10,617	—	Shares	Defined	2021-05-21
No filing history on record for this holder in this stock.